Quality Improvement in the Surgical Approach to Advanced Ovarian Cancer: The Mayo Clinic Experience

被引:90
作者
Aletti, Giovanni D. [1 ]
Dowdy, Sean C. [1 ]
Gostout, Bobbie S. [1 ]
Jones, Monica B. [1 ]
Stanhope, Robert C. [1 ]
Wilson, Timothy O. [1 ]
Podratz, Karl C. [1 ]
Cliby, William A. [1 ]
机构
[1] Mayo Clin, Dept Obstet & Gynecol, Rochester, MN 55905 USA
关键词
CYTOREDUCTIVE SURGERY; SURVIVAL; CARE; CARCINOMA; FRONTIER; OUTCOMES; NSQIP;
D O I
10.1016/j.jamcollsurg.2009.01.006
中图分类号
R61 [外科手术学];
学科分类号
摘要
BACKGROUND: After observing disparate rates of cytoreduction, we initiated efforts to improve outcomes through feedback and education, and we reassessed outcomes. STUDY DESIGN: Outcomes from group A (2006 and 2007, n = 105) were compared with those from the cohort predating quality-improvement efforts (group B, 2000 to 2003, n = 132). All stage IIIC ovarian cancer patients at our institution were evaluated for tumor dissemination, age, performance status, surgical complexity, residual disease (RD), morbidity, and mortality. A surgical complexity score previously described was used to categorize extent of operation. RESULTS: No significant differences in age, performance status, or extent of disease were observed between cohorts. Surgical complexity increased after initiation of quality improvement (mean surgical complexity score, 5.5 to 7.1; p < 0.001), rates of optimal RD (< 1 cm) improved from 77% to 85% (p = 0.157), and rates of complete resection of all gross disease rose from 31% to 43% (p = 0.188). In the subset of patients with carcinomatosis most likely to benefit from extended surgical resection, radical procedures were used more frequently (63% versus 79%; p = 0.028), rates of optimal debulking (RD < 1 cm) increased ( 64% to 79%), and the rate of RD = 0 increased from 6% to 24% ( p = 0.006). When disease was noted on the diaphragm, procedures to remove the disease were more frequently used (38% to 64%; p = 0.001). The rates of major perioperative morbidity (group B, 21% versus group A, 20%; p = 0.819) and 3-month mortality (8% versus 6%; p = 0.475) were not affected despite this more aggressive surgical approach. CONCLUSIONS: Analysis of outcomes with appropriate feedback and education is a powerful tool for quality improvement. We observed improvements in rates of cytoreduction and use of specific radical procedures, with no increase in morbidity as a result of this process. (J Am Coll Surg 2009;208:614-620. (C) 2009 by the American College of Surgeons)
引用
收藏
页码:614 / 620
页数:7
相关论文
共 18 条
[1]   Aggressive surgical effort and improved survival in advanced-stage ovarian cancer [J].
Aletti, GD ;
Dowdy, SC ;
Gostout, BS ;
Jones, MB ;
Stanhope, CR ;
Wilson, TO ;
Podratz, KC ;
Cliby, WA .
OBSTETRICS AND GYNECOLOGY, 2006, 107 (01) :77-85
[2]   Ovarian cancer surgical resectability: Relative impact of disease, patient status, and surgeon [J].
Aletti, GD ;
Gostout, BS ;
Podratz, KC ;
Cliby, WA .
GYNECOLOGIC ONCOLOGY, 2006, 100 (01) :33-37
[3]   A new frontier for quality of care in gynecologic oncology surgery: Multi-institutional assessment of short-term outcomes for ovarian cancer using a risk-adjusted model [J].
Aletti, Giovanni D. ;
Santillan, Antonio ;
Eisenhauer, Eric L. ;
Hu, Jae ;
Aletti, Giacomo ;
Podratz, Karl C. ;
Bristow, Robert E. ;
Chi, Dennis S. ;
Cliby, William A. .
GYNECOLOGIC ONCOLOGY, 2007, 107 (01) :99-106
[4]   Relationship among surgical complexity, short-term morbidity, and overall survival in primary surgery for advanced ovarian cancer [J].
Aletti, Giovanni D. ;
Dowdy, Sean C. ;
Podratz, Karl C. ;
Cliby, William A. .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2007, 197 (06) :676.e1-676.e7
[5]  
[Anonymous], 1989, GYNECOL ONCOL, V35, P125, DOI DOI 10.1016/0090-8258(89)90027-9
[6]  
[Anonymous], 2001, CROSS QUAL CHASM
[7]  
[Anonymous], ERR HUM BUILD SAF HL
[8]   Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis [J].
Bristow, RE ;
Tomacruz, RS ;
Armstrong, DK ;
Trimble, EL ;
Montz, FJ .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (05) :1248-1259
[9]   What is the optimal goal of primary cytoreductive surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? [J].
Chi, D. S. ;
Eisenhauer, E. L. ;
Lang, J. ;
Huh, J. ;
Haddad, L. ;
Abu-Rustum, N. R. ;
Sonoda, Y. ;
Levine, D. A. ;
Hensley, M. ;
Barakat, R. R. .
GYNECOLOGIC ONCOLOGY, 2006, 103 (02) :559-564
[10]   Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients [J].
Earle, CC ;
Schrag, D ;
Neville, BA ;
Yabroff, KR ;
Topor, M ;
Fahey, A ;
Trimble, EL ;
Bodurka, DC ;
Bristow, RE ;
Carney, M ;
Warren, JL .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2006, 98 (03) :172-180